PATENT CLAIM ANALYSIS

Application Number: 15958261
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "134100"]

Abstract:
The invention relates to the formulation of pharmaceutical compositions of etanercept. The invention also relates to methods of removing buffer and of formulating pharmaceutical compositions of etanercept.

Claim (Index 42):
A method of treating a patient having rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or psoriasis, comprising administering to said patient a pharmaceutical formulation, wherein the pharmaceutical formulation comprises: between 75 mM and 150 mM NaCl, between 5 mM and 100 mM arginine, between 0.5% and 2% (w/v) sucrose, and between 40 mg/mL and 100 mg/mL etanercept, wherein the pharmaceutical formulation comprises less than 2.0 mM total additional buffering agent, and the pH of the formulation is between 6.1 and 6.5.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.70588
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443557', '13654735', '13654770', '15716005', '14578179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7651179614526034
- 35 USC 102 Novelty (BERT): 0.531229056978868
- Combined Prediction Score: 0.7417290710052299
- Mean Citation Score: 307.20301200000006
- Max Citation Score: 332.59726
- Similarity Product: 245.5579135821832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test